Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
6.90T | 6.76T | 6.57T | 6.22T | 5.63T | 6.19T | Gross Profit |
3.63T | 3.54T | 3.33T | 3.27T | 2.87T | 2.70T | EBIT |
-25.01B | 560.01B | 632.71B | 713.85B | 603.43B | -1.36T | EBITDA |
869.71B | 1.47T | 1.53T | -47.75B | 6.21T | 109.78B | Net Income Common Stockholders |
75.69B | -227.65B | -970.14B | -1.71T | 4.99T | -961.58B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
5.50T | 6.19T | 7.30T | 6.09T | 7.80T | 3.68T | Total Assets |
47.83T | 46.72T | 43.94T | 47.54T | 45.75T | 37.26T | Total Debt |
21.60T | 21.36T | 20.32T | 22.32T | 19.55T | 14.27T | Net Debt |
16.10T | 15.18T | 13.39T | 17.15T | 14.89T | 10.90T | Total Liabilities |
33.63T | 33.49T | 33.29T | 35.84T | 33.79T | 29.88T | Stockholders Equity |
12.12T | 10.97T | 9.03T | 9.98T | 10.21T | 5.91T |
Cash Flow | Free Cash Flow | ||||
209.71B | -372.06B | 107.53B | 1.89T | -89.64B | -114.67B | Operating Cash Flow |
840.86B | 250.55B | 741.29B | 2.73T | 557.25B | 1.12T | Investing Cash Flow |
-1.72T | -841.46B | 547.58B | -3.02T | -1.47T | -4.29T | Financing Cash Flow |
-907.70B | -606.22B | 191.52B | 602.22B | 2.19T | 2.92T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $34.49B | 29.61 | 9.59% | 2.56% | -0.19% | -0.79% | |
76 Outperform | $186.06B | 10.48 | 18.23% | 6.14% | 0.93% | 56.97% | |
75 Outperform | $269.08B | 23.10 | 19.35% | 1.49% | 5.31% | 38.46% | |
71 Outperform | $52.40B | 31.20 | 8.54% | 2.87% | 0.19% | -49.68% | |
69 Neutral | $204.50B | 17.45 | 11.38% | 3.91% | 0.50% | -12.66% | |
61 Neutral | $14.79B | 5.90 | -3.99% | 6.20% | 2.67% | -30.30% | |
58 Neutral | $80.33B | 10.73 | 10.28% | 0.36% | -2.23% | ― |